Edmond DE Rothschild Holding S.A. Purchases 65,800 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI)

Edmond DE Rothschild Holding S.A. grew its position in shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 65.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 165,680 shares of the company’s stock after buying an additional 65,800 shares during the […]

Related Keywords

United States ,Stevee Krognes ,Vickil Sato ,Stifel Nicolaus ,Goldman Sachs Group ,Denali Therapeutics Inc ,Norges Bank ,Vanguard Group Inc ,Denali Therapeutics Company Profile ,Eventide Asset Management ,Nasdaq ,Exchange Commission ,Edmond De Rothschild Holding ,Principal Financial Group Inc ,Denali Therapeutics ,Free Report ,Financial Group ,Asset Management ,Director Vicki ,Director Steve ,Therapeutics Trading Down ,Get Free Report ,Therapeutics Inc ,Visit Holdingschannel ,Denali Therapeutics Daily ,